239 related articles for article (PubMed ID: 15337742)
1. SUMO-1 modification activated GATA4-dependent cardiogenic gene activity.
Wang J; Feng XH; Schwartz RJ
J Biol Chem; 2004 Nov; 279(47):49091-8. PubMed ID: 15337742
[TBL] [Abstract][Full Text] [Related]
2. PIAS1 is a GATA4 SUMO ligase that regulates GATA4-dependent intestinal promoters independent of SUMO ligase activity and GATA4 sumoylation.
Belaguli NS; Zhang M; Garcia AH; Berger DH
PLoS One; 2012; 7(4):e35717. PubMed ID: 22539995
[TBL] [Abstract][Full Text] [Related]
3. SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation.
Rogers RS; Horvath CM; Matunis MJ
J Biol Chem; 2003 Aug; 278(32):30091-7. PubMed ID: 12764129
[TBL] [Abstract][Full Text] [Related]
4. Myocardin sumoylation transactivates cardiogenic genes in pluripotent 10T1/2 fibroblasts.
Wang J; Li A; Wang Z; Feng X; Olson EN; Schwartz RJ
Mol Cell Biol; 2007 Jan; 27(2):622-32. PubMed ID: 17101795
[TBL] [Abstract][Full Text] [Related]
5. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.
Lee MB; Lebedeva LA; Suzawa M; Wadekar SA; Desclozeaux M; Ingraham HA
Mol Cell Biol; 2005 Mar; 25(5):1879-90. PubMed ID: 15713642
[TBL] [Abstract][Full Text] [Related]
6. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
[TBL] [Abstract][Full Text] [Related]
7. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
Ihara M; Yamamoto H; Kikuchi A
Mol Cell Biol; 2005 May; 25(9):3506-18. PubMed ID: 15831457
[TBL] [Abstract][Full Text] [Related]
8. Regulation of pokemon 1 activity by sumoylation.
Roh HE; Lee MN; Jeon BN; Choi WI; Kim YJ; Yu MY; Hur MW
Cell Physiol Biochem; 2007; 20(1-4):167-80. PubMed ID: 17595526
[TBL] [Abstract][Full Text] [Related]
9. Sumoylated SnoN represses transcription in a promoter-specific manner.
Hsu YH; Sarker KP; Pot I; Chan A; Netherton SJ; Bonni S
J Biol Chem; 2006 Nov; 281(44):33008-18. PubMed ID: 16966324
[TBL] [Abstract][Full Text] [Related]
10. SUMO modification of the Ets-related transcription factor ERM inhibits its transcriptional activity.
Degerny C; Monte D; Beaudoin C; Jaffray E; Portois L; Hay RT; de Launoit Y; Baert JL
J Biol Chem; 2005 Jul; 280(26):24330-8. PubMed ID: 15857832
[TBL] [Abstract][Full Text] [Related]
11. SUMO represses transcriptional activity of the Drosophila SoxNeuro and human Sox3 central nervous system-specific transcription factors.
Savare J; Bonneaud N; Girard F
Mol Biol Cell; 2005 Jun; 16(6):2660-9. PubMed ID: 15788563
[TBL] [Abstract][Full Text] [Related]
12. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
[TBL] [Abstract][Full Text] [Related]
13. Modification of promyelocytic leukemia zinc finger protein (PLZF) by SUMO-1 conjugation regulates its transcriptional repressor activity.
Kang SI; Chang WJ; Cho SG; Kim IY
J Biol Chem; 2003 Dec; 278(51):51479-83. PubMed ID: 14527952
[TBL] [Abstract][Full Text] [Related]
14. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
[TBL] [Abstract][Full Text] [Related]
15. PIAS proteins promote SUMO-1 conjugation to STAT1.
Ungureanu D; Vanhatupa S; Kotaja N; Yang J; Aittomaki S; Jänne OA; Palvimo JJ; Silvennoinen O
Blood; 2003 Nov; 102(9):3311-3. PubMed ID: 12855578
[TBL] [Abstract][Full Text] [Related]
16. ZNF76, a novel transcriptional repressor targeting TATA-binding protein, is modulated by sumoylation.
Zheng G; Yang YC
J Biol Chem; 2004 Oct; 279(41):42410-21. PubMed ID: 15280358
[TBL] [Abstract][Full Text] [Related]
17. A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo.
Antoine K; Prosperi MT; Ferbus D; Boule C; Goubin G
Mol Cell Biochem; 2005 Mar; 271(1-2):215-23. PubMed ID: 15881673
[TBL] [Abstract][Full Text] [Related]
18. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.
Subramanian L; Benson MD; Iñiguez-Lluhí JA
J Biol Chem; 2003 Mar; 278(11):9134-41. PubMed ID: 12511558
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor Sp3 is silenced through SUMO modification by PIAS1.
Sapetschnig A; Rischitor G; Braun H; Doll A; Schergaut M; Melchior F; Suske G
EMBO J; 2002 Oct; 21(19):5206-15. PubMed ID: 12356736
[TBL] [Abstract][Full Text] [Related]
20. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator.
Karvonen U; Jääskeläinen T; Rytinki M; Kaikkonen S; Palvimo JJ
J Mol Biol; 2008 Oct; 382(3):585-600. PubMed ID: 18656483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
